JamesLouisJanuzziJr.MD

Cardiology • Boston, MA

Heart Failure & Transplantation, Non-Invasive Cardiology

Hutter Family Professor of Medicine, Harvard Medical School and Senior Staff Physician in Medicine Massachusetts General Hospital.

Join to view full profile

Dr. Januzzi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Januzzi's full profile

Already have an account?

Office
32 Fruit St
Boston, MA 02114
Phone+1 617-726-3443

Fax+1 617-724-6767

Summary

Dr. James Januzzi is a cardiologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from New York Medical College and has been in practice 23 years. He also speaks multiple languages, including Italian. He specializes in adult general cardiology, with a focus on heart failure, coronary artery disease and myocardial infarction.

Education & Training

Massachusetts General HospitalFellowship, Cardiovascular Disease, 2000
Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1997
Brigham and Women's HospitalInternship, Internal Medicine, 1994 - 1995
New York Medical CollegeClass of 1994
College of the Holy CrossB.A., Biology, 1984 - 1988

Certifications & Licensure

MA State Medical License 1996 - 2026

Awards, Honors, & Recognition

Top 1% Most Cited Researcher Internationally Clarivate, Inc, 2017
Simon Dack Award American College of Cardiology, 2013
Elite Reviewer European Heart Journal, 2012
Brian A. McGovern Memorial Award for Excellence in Clinical Teaching Massachusetts General Hospital, 2007
Sheila and John Balson Cardiac Scholar Award 2007
Nathaniel Bowditch Award Massachusetts General Hospital, 2006
Best of Boston, Cardiology Boston Magazine, 2006-2007
America’s Top Cardiologists 2006
Who’s Who in Science and Research 2006
Who’s Who in Medicine 2006
Visiting Professor, Alpha Omega Alpha New York Medical College, 2005
Outstanding Speaker Award American Association for Clinical Chemistry, 2005, 2009, 2013
Best Doctors 2005
Hospital Award for Excellence: the PRIDE Study, Clinical Research Day Massachusetts General Hospital, 2004
Fellow of the American College of Cardiology American College of Cardiology, 2003
Partners in Excellence Award Massachusetts General Hospital, 2002
Bristol Myers Squibb Cardiology Fellows Forum Scholarship Massachusetts General Hospital, 1999
Roman W. DeSanctis, M.D., Clinical Scholar Award Massachusetts General Hospital, 1998
Dr. and Mrs. David Harrison Scholarship Award New York Medical College, 1994
Citation for Service, Cor et Manus New York Medical College, 1994
David Spiro, M.D., Ph.D., Memorial Award in Pathology New York Medical College, 1994
Eileen H. Pike, M.D., Ph.D., Memorial Award in Microbiology New York Medical College, 1994
Stephen P. Jewett, M.D., Memorial Award in Psychiatry New York Medical College, 1994
Irving Innerfield, M.D., Memorial Award in Internal Medicine New York Medical College, 1994
President, Iota Chapter, Alpha Omega Alpha Medical Honor Society New York Medical College, 1993
First Prize, New York Medical College Research Forum New York Medical College, 1992
New York Medical College Trustee's Scholarship New York Medical College, 1991
Top MD Consumers Checkbook
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting. Start of enrollment: 2005 Sep 01
Completed
Not Applicable
The Ischemia Modified Albumin In Diagnosing Ischemic New Events Start of enrollment: 2006 Sep 01
Terminated
Peripheral Venous Oxygen Saturation and Biomarkers to Estimate Cardiac Output and Filling Pressures in Heart Failure Start of enrollment: 2007 Dec 01
Completed
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases Start of enrollment: 2008 Sep 01
Completed
Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study Start of enrollment: 2009 Mar 01
Withdrawn
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Start of enrollment: 2010 Sep 01
Completed
Phase 4
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial Start of enrollment: 2012 Mar 01
Completed
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment Start of enrollment: 2012 Dec 01
Terminated
Not Applicable
Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study Start of enrollment: 2015 Dec 01
Active, not recruiting
DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR Start of enrollment: 2021 Apr 11
Completed
TRANSFORM Heart Failure With Reduced Ejection Fraction Start of enrollment: 2021 Oct 01
Withdrawn
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Emergency department clinical performance of ADVIA Centaur n-terminal prohormone of B-type natriuretic peptide assay.
W Frank Peacock, Jennifer Snyder, Chadwick Brown, Yan Liu Liu, Charles K Cooper
Clinica Chimica Acta; International Journal of Clinical Chemistry. 2025-01-01
POINT: Statistical Non-Significance, Likelihood Ratio, and The Interpretation of Clinical Trial Evidence: Insights from Heart Failure Randomized Trials.
Muhammad Shahzeb Khan, Adeena Jamil, James L Januzzi, Muteia Shakoor, Monica M Bennett
Journal of Cardiac Failure. 2024-12-01
1 citations
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa, Theodore P Abraham, Douglas Marshall Brinkley
European Heart Journal. 2024-11-08

Journal Articles

Effects of Canagliflozin on Amino-Terminal Pro–B-type Natriuretic Peptide Implications for Cardiovascular Risk Reduction
James Januzzi Jr., MD, JACC: Cardiovascular Imaging
The Need to Innovate and Accelerate Clinical Trial Performance BeAT the Clock
James Januzzi Jr., MD, JACC: Cardiovascular Imaging
Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart Disease
James L Januzzi, Darren K Mcguire, Javed Butler, Journal of Cardiac Failure
NT-proBNP Prognostic Value Is Maintained in Elderly and Very Elderly Patients with Chronic Systolic Heart Failure
James Januzzi Jr., MD, International Journal of Cardiology
Management of Patients with Diabetes and Heart Failure with Reduced Ejection Fraction: An International Comparison
James L Januzzi, Mikhail Kosiborod, Frederick A Masoudi, Darren K McGuire, Suzanne V Arnold, Gregg C Fonarow, Diabetes, Obesity and Metabolism
Which heart failure patients profit from natriuretic peptide guided therapy? A meta analysis from individual patient data of randomized trials
Brunner-Larocca HP, Eurlings L, Richards AM, Pfisterer M, Dahlstrom U, Pinto YM, Karlstrom P, Erntell H, Berger R, Persson H, O’Connor CM, Moertl D, Gaggin HK, Frampto..., Eur Jour Heart Fail, 1/30/2015
Clinical presentation and outcome by age categories in acute heart failure: Results from an international observational cohort
Teixeira A, Parenica J, Park JJ, Ishihara S, Al-Habib KF, Laribi S, Maggioni A, Miro O, Sato N, Kajimoto K, Cohen-Solal A, Fairman E, Lassus J, Mueller C, Peacock WF, ..., Eur Jour Heart Fail, 1/30/2015
Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction
Frioes F, Lourenco P, Laszczynska O, Almeida PB, Guimaraes JT, Azevedo A, Bettencourt P, Clin Res Cardiol, 1/14/2015
Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richard..., Intensive Care Med, 1/14/2015
B-type natriuretic peptides as a marker of vascular remodeling and subclinical atherosclerosis in asymptomatic hypertensive subjects
Pastormerlo LE, Maffei S, Della Latta D, Eng D, Vladislav C, Susini C, Berti S, Clerico A, Passino C, Emdin M, and Chiappino D, Eur J Prev Cardiol, 1/2/2015
Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: Results from the ProBNP Outpatient Tai...
Gandhi PU, Szymonifka J, Motiwala SR, Belcher AS, Gaggin HK, J Card Fail, 1/1/2015
ST2 Pathogenetic Profile in Ambulatory Heart Failure Patients
Bayes-Genis A, Gaggin HK, de Antonio M, Motiwala SR, Zamora E, Galán A, Domingo M, Urrutia A, Lupón J, J Card Fail, 1/1/2015
Outcomes of patients with acute decompensated heart failure managed by cardiologists versus non-cardiologists
Uthamalingam S, Kandala J, Selvaraj V, Martin W, Daley M, Patvardhan E, Capodilupo R, Moore SA, Am Jour Cardiol, 1/1/2015
Major bleeding risk prediction using CKD-EPI and MDRD equations in acute coronary syndrome
Flores-Blanco PJ, López-Cuenca Á, Marín F, Sánchez-Martínez M, Quintana-Giner M, Romero-Aniorte AI, Valdés M, Manzano-Fernández S, Eur J Clin Invest, 1/1/2015
Biomarker assist score for reverse remodeling prediction in heart failure: the ST2-R2 score
Lupon J, Gaggin HK, de Antonio M, Domingo M, Galan A, Zamora E, Vila J, Penafiel J, Urrutia A, Ferrer E, Vallejo N, Bayes-Genis A, Int Jour Cardiol, 1/1/2015
Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction
Gandhi PU, Motiwala SR, Belcher AM, Gaggin HK, Weiner RB, Baggish AL, Fiuzat M, Brunner-Larocca HP, Am Heart J, 1/1/2015
Sensitive troponin assays in patients with suspected acute coronary syndrome: results from the multicenter Rule Out Myocardial Infarction Using Computer Assisted Tomog...
Sharma U, Zakroysky P, Truong QA, Woodard PK, Pope JH, Hauser T, Mayrhofer T, Nagurney JT, Schoenfeld D, Peacock WF, Fleg JL, Wiviott S, Pang PS, Udelson J, and Hoffma..., Am Heart J, 1/1/2015
Analysis of BAG3 concentrations in patients with acutely decompensated heart failure
Gandhi PU, Gaggin HK, Belcher AM, Harisiades JE, Basile A, Falco A, Rosati A, Turco MC, Clin Chim Acta, 1/1/2015
Concentrations of highly sensitive cardiac troponin I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure
Motiwala SR, Gaggin HK, Gandhi PU, Belcher A, Weiner RB, Baggish AL, Szymonifka J, J Cardiovasc Transl Res, 1/1/2015
Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure
Zhang R, Zhang Y, An T, Guo X, Yin S, Wang Y, Cappola TP, Zhang J, Biomark Med, 1/1/2015
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
Vodovar N, Séronde MF, Laribi S, Gayat E, Lassus J, Boukef R, Nouira S, Manivet P, Samuel JL, Logeart D, Cohen-Solal A, Richards AM, Launay JM, Mebazaa A; GREAT Network, JACC Heart Fail, 1/1/2015
Associations of GDF-15 and ST2 with subclinical vascular brain injury and incident stroke
Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, Vasan RS, Seshadri S, Stroke, 1/1/2015
Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treatedwith doxorubicin, taxanes, and trastusuzmab
Putt M, Hahn VS, Sawaya H, Sebag IA, Plana JC, Picard MH, Carver JR, Halpern EF, Kuter I, Passeri J, Cohen V, Banchs J, Martin RP, Gerszten RE, Scherrer-Crosbie M, and..., Clin Chem, 1/1/2015
Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study
Huffman JC, Beale EE, Beach SR, Celano CM, Belcher AM, Moore SV, Suarez L, Gandhi PU, Motiwala SR, Gaggin HK, Contemp Clin Trials, 1/1/2015
The potential role of natriuretic peptide guided therapy for hospitalized heart failure patients
Maisel AS, Xue Y, Pang PS, Pina IL, deFilippi C, and Butler J, J Card Fail, 1/1/2015
Join now to see all

Books/Book Chapters

Heart Failure: The Expert’s Approach
Chapter: Biomarker guided heart failure management
Januzzi JLEditors: Alan Maisel and Gerasimos Filippatos.Jaypee Brothers, New Delhi, IN2014
Pocket Primary Care: A Massachusetts General Hospital Handbook
Chapter: Pre-operative risk assessment
Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
Pocket Primary Care: A Massachusetts General Hospital Handbook
Chapter: Dyslipidemia
Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
Pocket Primary Care: A Massachusetts General Hospital Handbook
Chapter: Chest pain and non-invasive testing
Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
Pocket Primary Care: A Massachusetts General Hospital Handbook
Chapter: Atrial fibrillation and flutter
Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
Pocket Primary Care: A Massachusetts General Hospital Handbook
Chapter: Syncope
Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
Clinical Decision Support: Cardiology
Chapter: Using biomarkers to follow patients with heart failure
Januzzi JLEditors: Barry H. Greenberg, Deepak L. Bhatt, Willliam E. Boden, Blaise A. Carabello, Gerald Naccarelli.Decision Support in Medicine, LLC, Wilmington, DE2012
Cardiac biomarkers: Expert Advice for Clinicians
Chapter: ST2
Kim HN and Januzzi JLEditors: Alan Maisel.Jaypee Brothers, New Delhi, IN2012
Protocols in Intensive Care
Chapter: Natriuretic peptide testing in critical care
van Kimmenade RRJ and Januzzi JLMarban Press, Madrid, SpainEdition 1st,2011
Handbook of Chronic Kidney Disease Management
Chapter: Heart failure
van Kimmenade RRJ and Januzzi JLEditors: John T. Daugirdas.Lippincott, Williams and Wilkins, Philadelphia, PA2011
Biomarkers of Heart Disease
Chapter: Use of B-type natriuretic peptide testing in diagnosis of heart failure
Martinez-Rumayor A and Januzzi JLEditors: James deLemos.American Heart Association press, Dallas TXEdition 1st,2009
Cardiac Biomarkers in Clinical Practice
Chapter: Natriuretic peptide testing for diagnostic evaluation of patients with suspected acute heart failure
Mohammed AA and Januzzi JLEditors: James L. Januzzi.Jones and Bartlett, Sudbury, MAEdition 1st,2009
Irwin and Rippe’s Manual
Chapter: Complicated myocardial infarction
Martinez-Rumayor A and Januzzi JLEditors: Richard Irwin and James Rippe.Lippincott, Williams and Wilkins, Philadelphia, PA2008
Markers in cardiology: A case oriented approach
Chapter: B-type natriuretic peptide testing
Baggish AL and Januzzi JLEditors: Jesse Adams, Fred Apple, and Allan Jaffe.American Heart Association, Dallas TX2007
Irwin and Rippe’s Intensive Care Medicine
Chapter: Acute aortic syndromes
Ptasek L, Isselbacher EMEditors: Richard Irwin and James Rippe.Lippincott, Williams and Wilkins, Philadelphia, PAEdition 6th,2007
Harrison’s Neurology in Clinical Medicine
Chapter: Laboratory values of clinical importance
Sluss P, Lewandrowski KBEdition 1st,2006
Harrison’s Rheumatology
Chapter: Laboratory values of clinical importance
Sluss P, Lewandrowski KBEdition 1st,2006
Harrison’s Endocrinology
Chapter: Laboratory values of clinical importance
Sluss P, Lewandrowski KBEdition 1st,2006
Principles of Molecular Medicine
Chapter: The genetics of aortic disease
Das S, Isselbacher EMEditors: Runge MS and Patterson CW.Humana Press, Totowa, NJ2005
Harrison’s Principles of Internal Medicine
Chapter: Laboratory values of clinical importance
Kratz A, Lewandrowski KBEdition 16th,2004
The Massachusetts General Hospital Handbook of General Hospital Psychiatry
Chapter: The psychiatric management of patients with cardiac disease
Huffman JC, Stern TAEditors: Theodore Stern, Gregory Fricchione, Ned Cassem, Michael Jellinek, and Jerrold Rosenbaum.Mosby, St. Louis, MOEdition 5th,2004
Diseases of the nervous system
Chapter: Neurologic manifestations of cardiovascular diseases
Januzzi JL, and McKhann GMEditors: Arthur Asbury, Guy McKhann, W. Ian McDonald, Peter J. Goadsby, and Justin C. McArthur.Cambridge University Press, Cambridge, UK2002
Assessing and modifying the vulnerable atherosclerotic plaque
Chapter: Activities that trigger plaque disruption
Singh JP, Muller JEEditors: Valentin Fuster.Futura Publishing Co., Armonk, NY2002
Applications of antisense therapies to restenosis
Chapter: The pathobiology of restenosis: A paradigm based on clinical and experimental studies
Januzzi JL, and Edelman EREditors: LeRoy Rabbani.Kluwer Academic Publishers, Norwell, MA1999
Heart Failure: Principles and Clinical Management
Chapter: Novel biomarkers and diagnostics
Bhardwaj A and Januzzi JLEditors: William Abraham and Henry Krum.McGraw Hill, New York, NY
Join now to see all

Abstracts/Posters

Utility of Soluble ST2 Concentrations for the Evaluation of Dyspneic Patients
Januzzi JL, American Heart Association Meetings, Chicago IL, 1/1/2006

Lectures

Featured Clinical Research III
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Changing Paradigm in Cardiovascular Risk Reduction in Diabetes
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Changing Paradigm in Cardiovascular Risk Reduction in Diabetes
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Clinician Wellness Intensive I Featuring the 50th Annual Louis F. Bishop Keynote
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Clinician Wellness Intensive I Featuring the 50th Annual Louis F. Bishop Keynote
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Wellness Intensive: Closing Statements
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Clinician Wellness Intensive II
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Acute Coronary Syndromes
Multiple Locations, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2011, 2012, 2013, 2014 - 1/1/2015
What’s New in Cardiac Biomarkers?
Harvard University, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014 - 1/1/2015
Biomarker guided heat failure therapy
UCSD - 1/1/2015
Heart failure biomarkers in clinical trials
Harvard Clinical Research Institute, Boston, MA, 2015 - 1/1/2015
Biomarker Guided Heart Failure Management
Multiple Locations, 2008, 2010, 2011, 2012, 2013, 2014 - 1/1/2015
Biomarkers in Heart Failure
Multiple Locations, 2011, 2013, 2014 - 1/1/2015
The evolving role of heart failure biomarkers
Allegheny Medical Center, Pittsburgh, PA, 2014; Morristown Medical Center, Morristown, NJ, 2015 - 1/1/2015
What’s new in cardiovascular biomarkers?
Robert Wood Johnson Medical Center, Hanover, NJ - 1/1/2015
How to triage ACS patients: hsTn versus cardiac CTA
San Diego, CA - 1/1/2015
Heart Failure Biomarkers: An Overview
Baltimore, MD - 1/1/2015
Biomarker Guided Heart Failure Therapy
Paris, FR, 2011; Amsterdam, NE, 2013; Buenos Aires, AR, 2015 - 1/1/2015
Biomarkers for management of heart failure, across the spectrum
Paris, FR - 1/1/2015
Biomarkers in heart failure: guideline considerations
Buenos Aires, AR - 1/1/2015
Biomarkers of Heart Failure
Yokohama, Japan - 1/1/2015
Natriuretic peptides: evolving understanding
Yokohama, Japan - 1/1/2015
Acute Coronary Syndromes: Diagnostic and Therapeutic Options in 2014
Harvard University - 1/1/2014
Biomarker guided heart failure
Mt. Sinai Medical School - 1/1/2014
Cardiac troponin testing
St. Anne’s Hospital, Fall River, MA - 1/1/2014
Join now to see all

Other

Cardiac Biomarkers and Heart Failure
Gaggin HK and Januzzi JL
http://www.acc.org/latest-in-cardiology/articles/2015/02/09/13/00/cardiac-biomarkers-and-heart-failure
1/10/2015
How Do ST2 and Galectin-3 Compare for Prognosis in Heart Failure Patients?
Januzzi JL
http://biomarkers.cardiosource.org/Ask-the-Expert/2014/08/How-Do-ST2-and-Galectin3-Compare-for-Prognosis-in-Heart-Failure-Patients.aspx.
1/21/2014
In 5 years, which markers will we be using to assess risk in HF patients: natriuretic peptides, troponin, galectin-3, others?
Gandhi PU, and Januzzi JL
http://biomarkers.cardiosource.org/ask-the-expert.aspx.
1/5/2014
Natriuretic peptides are useful to guide heart failure management: Pro
Januzzi JL, Cardiac Biomarkers
http://biomarkers.cardiosource.org/ask-the-expert-pro-vs-con-debate.aspx
1/12/2013
What Biomarkers Are Useful for Detection of Myocardial Ischemia?
Januzzi JL, Cardiac Biomarkers
1/4/2011
ST2: A Novel Biomarker in Heart Failure
Januzzi JL, Cardiac Biomarkers
http://biomarkers.cardiosource.org/Video-News/Video/Soluble-ST2.aspx?w_nav=Search&WT.oss=januzzi&WT.oss_r=28&
1/10/2010
Non-ACS Causes of Troponin Elevation
Kim HN and Januzzi JL, Cardiac Biomarkers
http://biomarkers.cardiosource.org/Hot-Topics/2010/09/Causes-of-Non-ACS-Related-Troponin-Elevations.aspx?w_nav=Search&WT.oss=januzzi&WT.oss_r=28&
1/8/2010
Risk factors, management, and outcomes of acute aortic dissection: Observations from the International Registry of Aortic Dissection (IRAD)
Januzzi JL, and Isselbacher EM, Harrison’s Online
http://harrisons.accessmedicine.com/server-java/Arknoid/amed/harrisons/ex_editorials/edl3622_p01.html
Hot topic: Causes of non-ACS related troponin elevations
Kim HN and Januzzi JL, Cardiosource
http://biomarkers.cardiosource.org/Hot-Topics/2010/09/Causes-of-Non-ACS-Related-Troponin-Elevations.aspx
Unstable angina/non-ST segment elevation myocardial infarction: pathophysiology
Januzzi JL, ACC Self Assessment Program 8
http://author.cardiosource.org/Certified-Education/Certified-Learning/SAPs/2011/ACCSAP8
Join now to see all

Authored Content

Heart Failure Biomarkers in COVID-19July 2020
Heart Failure Biomarkers in COVID-19July 2020
The Need to Innovate and Accelerate Clinical Trial Performance BeAT the ClockJuly 2020
Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart DiseaseNovember 2018
Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018
Evaluating Chest Pain in the Emergency Department Searching for the Optimal GatekeeperFebruary 2018
Evaluating Chest Pain in the Emergency Department Searching for the Optimal GatekeeperFebruary 2018
Addition or Removal of Guideline Directed Medical Therapy in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction Relative to Change in Symptom Severity: An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®January 2018
Evolution of Natriuretic Peptide Biomarkers in Heart Failure: Implications for Clinical Care and Clinical Trials☆January 2018
Addition or Removal of Guideline Directed Medical Therapy in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction Relative to Change in Symptom Severity: An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®January 2018
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure TreatmentDecember 2017
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
Join now to see all

Press Mentions

The Evolution of Cardiac Biomarker Testing in Cardiology (James Januzzi, MD)September 23rd, 2024
Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies ShowMay 21st, 2024
Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-Driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney DiseaseNovember 3rd, 2022
Join now to see all

Committees

Trustee, Board of Trustees, American College of Cardiology 2018 - Present

Professional Memberships

American College of Cardiology - ACC
Member

Other Languages

Italian